News

Tomas Cihlar and Wesley Sundquist
Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...
Technology Networks1d
Enzyme-Blocking Drugs Outperform Existing Coronavirus Antivirals
Researchers have developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially ...
News Medical on MSN2d
Scientists develop promising new drug candidates against coronaviruses
A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...
The Daily of the University of Washington9d
Research in action: UW leads breakthroughs in long-acting HIV therapy
Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...
Gilead posts profit, says HIV prevention drug on track for mid-June
Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...
BioPharma Dive12h
Gilead leans on HIV drugs as oncology sales slow
The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...
Tomas Cihlar and Wesley Sundquist Are on the 2025 TIME100
A jury reached a verdict in Harford County on Monday in the Rachel Morin murder trial. Victor Martinez-Hernandez, 24, was ...